offline
Abbott (ABT) Q3 Earnings and Revenues Surpass Estimates
Abbott (ABT) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.90 per share. This compares to earnings of $0.84 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 8.89%. A quarter ago, it was expected that this maker of infant formula, medical devices and drugs would post earnings of $0.43 per share when it actually produced earnings of $0.57, delivering a surprise of 32.56%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Abbott, which belongs to the Zacks Medical - Products industry, posted revenues of $8.85 billion for the quarter ended September 2020, surpassing the Zacks Consensus Estimate by 4.67%. This compares to year-ago revenues of $8.08 billion.
...
https://finance.yahoo.com/news/abbott-ab...12874.html
![[Bild: ABTc1dl1244.png]](https://finviz.com/publish/102520/ABTc1dl1244.png)
Abbott (ABT) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.90 per share. This compares to earnings of $0.84 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 8.89%. A quarter ago, it was expected that this maker of infant formula, medical devices and drugs would post earnings of $0.43 per share when it actually produced earnings of $0.57, delivering a surprise of 32.56%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Abbott, which belongs to the Zacks Medical - Products industry, posted revenues of $8.85 billion for the quarter ended September 2020, surpassing the Zacks Consensus Estimate by 4.67%. This compares to year-ago revenues of $8.08 billion.
...
https://finance.yahoo.com/news/abbott-ab...12874.html
__________________
